# Utility Assessment of a Pharmacy-to-Dose Daptomycin

> **NCT05224687** · — · UNKNOWN · sponsor: **Methodist Health System** · enrollment: 100 (estimated)

## Conditions studied

- Antibiotics Causing Adverse Effects in Therapeutic Use

## Interventions

- **OTHER:** Retroactive review of patient data of those receiving a dose of daptomycin

## Key facts

- **NCT ID:** NCT05224687
- **Lead sponsor:** Methodist Health System
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-12-15
- **Primary completion:** 2022-12-15
- **Final completion:** 2022-12-15
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2022-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05224687

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05224687, "Utility Assessment of a Pharmacy-to-Dose Daptomycin". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT05224687. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*